AMGEN
USPTO Trademark Record · Serial No. 73814395
Trademark details
It was initially claimed by AMGEN INC. on 19890724.
That brand applies to the following goods and services:PHARMACEUTICAL PREPARATIONS, NAMELY, ERYTHROPOIETIN FOR USE IN TREATING CHRONIC ANEMIA, GRANULOCYTE COLONY STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR FOR USE IN RESTORING THE LEVEL OF WHITE BLOOD CELLS, HEPATITIS B VACCINE, [ INTERFERON AND ] INTERLEUKIN 2 FOR USE IN ANTICANCER AND ANTIVIRAL APPLICATIONS, EPIDERMAL GROWTH FACTOR AND PLATELET DERIVED GROWTH FACTOR FOR USE IN TREATING SURGICAL OR SOFT TISSUE DAMAGE; [ AND PHARMACEUTICAL PREPARATIONS FOR ANIMAL HEALTH C, GENETIC ENGINEERING RESEARCH AND DEVELOPMENT SERVICES FOR OTHERS.
Currently that trademark is represented by trademark attorney(s): Mark I. Feldman, Christina L. Martini.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the AMGEN trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
